Cite
Uemura M, Kim HM, Hata T, et al. First-line cetuximab-based chemotherapies for patients with advanced or metastatic . Mol Clin Oncol. 2016;5(2):375-379doi: 10.3892/mco.2016.938.
Uemura, M., Kim, H. M., Hata, T., Sakata, K., Okuyama, M., Takemoto, H., Fujii, H., Fukuzaki, T., Morita, T., Hata, T., Takemasa, I., Satoh, T., Mizushima, T., Doki, Y., Mori, M. (2016). First-line cetuximab-based chemotherapies for patients with advanced or metastatic . Molecular and clinical oncology, 5(2), 375-379. https://doi.org/10.3892/mco.2016.938
Uemura, Mamoru, et al. "First-line cetuximab-based chemotherapies for patients with advanced or metastatic ." Molecular and clinical oncology vol. 5,2 (2016): 375-379. doi: https://doi.org/10.3892/mco.2016.938
Uemura M, Kim HM, Hata T, Sakata K, Okuyama M, Takemoto H, Fujii H, Fukuzaki T, Morita T, Hata T, Takemasa I, Satoh T, Mizushima T, Doki Y, Mori M. First-line cetuximab-based chemotherapies for patients with advanced or metastatic . Mol Clin Oncol. 2016 Aug;5(2):375-379. doi: 10.3892/mco.2016.938. Epub 2016 Jun 17. PMID: 27446583; PMCID: PMC4950727.
Copy
Download .nbib